1915P The lenvatinib/pembrolizumab combination induces long lasting and complete responses in patients with metastatic anaplastic or poorly differentiated thyroid carcinoma: Results from a retrospective study and first results from the prospective phase II ATLEP trial
| Autor: | Dierks, C., Seufert, J., Ruf, J., Duyster, J., Thomusch, O., Miething, C., Zielke, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S1085-S1085 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|